Bell Edward C, Ravis William R, Lloyd Kimberly Braxton, Stokes Thomas J
College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
Ann Pharmacother. 2007 Feb;41(2):229-34. doi: 10.1345/aph.1H602. Epub 2007 Feb 6.
St. John's wort is a popular herbal supplement that has been involved in various herb-drug interactions. Experimental findings suggest that the supplement may impact CYP2C9 metabolism. CYP2C9 is responsible for the irreversible metabolism of ibuprofen.
To examine the effect of 3 weeks of St. John's wort administration on the stereoselective pharmacokinetics of ibuprofen.
Eight male subjects participated in this study. The single-dose pharmacokinetics of ibuprofen were evaluated before and after 21 days of St. John's wort administration. Plasma ibuprofen concentrations were determined, using a stereoselective, reversed-phase HPLC assay. Model independent methods were used to evaluate the pharmacokinetics of each ibuprofen enantiomer. Data were analyzed by 2 way ANOVA testing and confidence interval testing.
S(+)-ibuprofen mean +/- SD AUC and maximum concentration (C(max)) values were 131.6 +/- 26.8 microg x h/mL and 31.8 +/- 7.33 microg/mL, respectively, for control samples and 122.4 +/- 32.9 microg x h/mL and 33.6 +/- 7.83 microg/mL, respectively, after St. John's wort treatment. R(-)-ibuprofen mean AUC and C(max) values were 85.1 +/- 26.6 microg x h/mL and 28.4 +/- 8.72 microg/mL, respectively, for control samples and 87.7 +/- 30.1 microg x h/mL and 30.0 +/- 8.97 microg/mL, respectively, for St. John's wort treatment samples. St. John's wort administration resulted in no significant effects on the C(max) and AUC of either stereoisomer. A 31% decrease in S(+)-ibuprofen mean residence time (p = 0.02) was observed.
St. John's wort administration for 21 days had no apparent clinically important impact on the single-dose pharmacokinetic parameters of S(+)- and R(-)-ibuprofen. Although St. John's wort treatment appears to significantly reduce the mean residence time of S-ibuprofen, no ibuprofen dose adjustments appear warranted when the drug is administered orally with St. John's wort, due to the lack of significant change observed in ibuprofen AUC and C(max) for either enantiomer.
圣约翰草是一种广受欢迎的草药补充剂,它涉及多种草药与药物的相互作用。实验结果表明,这种补充剂可能会影响CYP2C9的代谢。CYP2C9负责布洛芬的不可逆代谢。
研究服用3周圣约翰草对布洛芬立体选择性药代动力学的影响。
8名男性受试者参与了本研究。在服用圣约翰草21天前后,评估了布洛芬的单剂量药代动力学。使用立体选择性反相高效液相色谱法测定血浆布洛芬浓度。采用非模型方法评估每种布洛芬对映体的药代动力学。数据通过双向方差分析测试和置信区间测试进行分析。
对照样本中,S(+)-布洛芬的平均±标准差AUC和最大浓度(C(max))值分别为131.6±26.8μg·h/mL和31.8±7.33μg/mL,服用圣约翰草后分别为122.4±32.9μg·h/mL和33.6±7.83μg/mL。对照样本中,R(-)-布洛芬的平均AUC和C(max)值分别为85.1±26.6μg·h/mL和28.4±8.72μg/mL,服用圣约翰草的样本分别为87.7±30.1μg·h/mL和30.0±8.97μg/mL。服用圣约翰草对两种立体异构体的C(max)和AUC均无显著影响。观察到S(+)-布洛芬的平均驻留时间下降了31%(p = 0.02)。
服用21天圣约翰草对S(+)-和R(-)-布洛芬的单剂量药代动力学参数没有明显的临床重要影响。虽然服用圣约翰草似乎显著缩短了S-布洛芬的平均驻留时间,但由于两种对映体的布洛芬AUC和C(max)均未观察到显著变化,因此当布洛芬与圣约翰草一起口服给药时,似乎无需调整布洛芬剂量。